.

Edwards Lifesciences reported $645M in Ordinary Share Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Abiomed ABMD:US $ 0.46M 0M
Atricure ATRC:US $ 0.05M 0M
Baxter International BAX:US $ 683M 0M
Becton, Dickinson and BDX:US $ 365M 0M
Cooper Companies COO:US $ 5.4M 0M
Cryolife CRY:US $ 0.42M 0M
Dexcom DXCM:US $ 0.4M 0.3M
Edwards Lifesciences EW:US $ 645M 2.1M
Globus Medical GMED:US $ 0.1M 0M
Hologic HOLX:US $ 3M 0M
Icu Medical ICUI:US $ 2.39M 0M
Inogen INGN:US $ 0.02M 0M
Insulet PODD:US $ 0.1M 0M
Integra Lifesciences IART:US $ 0.9M 0M
Masimo MASI:US $ 0.1M 0.04M
Medtronic MDT:US $ 0.13M 0M
Merit Medical Systems MMSI:US $ 651.93M 5.56M
Nuvasive NUVA:US $ 0.06M 0M
Tandem Diabetes Care TNDM:US $ 0.06M 0M
Teleflex TFX:US $ 47.94M 0.01M
Zimmer Biomet Holdings Inc ZBH:US $ 3.1M 0